Showing results (11-20 of 138) with videos related to
Sort By:
Pageof 14
Muscle & Nerve|October 21, 2016
Sarcopenia, age, atrophy, and myopathy: Mitochondrial oxidative enzyme activitiesAlan Pestronk, Richard Keeling, Rati ChoksiJournal of Neurology, Neurosurgery, and Psychiatry|June 29, 2010
Motor neuropathies and serum IgM binding to NS6S heparin disaccharide or GM1 gangliosideAlan Pestronk, Miguel Chuquilin, Rati ChoksiMuscle & Nerve|July 13, 2002
Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodiesGlenn Lopate, Rati Choksi, Alan PestronkJournal of Clinical Neuromuscular Disease|March 2, 2026
Progressive Myopathy and Respiratory Failure in a 7-Year-Old Boy With m.3251A>G MT-TL1 MutationDaria Hoang, Alan Pestronk, Jafar KafaieMuscle & Nerve|June 15, 2010
Vascular pathology in dermatomyositis and anatomic relations to myopathologyAlan Pestronk, Robert E Schmidt, Rati ChoksiJournal of the Neurological Sciences|December 23, 2008
Inflammatory myopathies with mitochondrial pathology and protein aggregatesPeyker Temiz, Conrad C Weihl, Alan PestronkArchives of Neurology|February 16, 2005
Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisoloneGlenn Lopate, Alan Pestronk, Muhammad Al-LoziCurrent Opinion in Rheumatology|September 10, 2010
Mitochondrial pathology in immune and inflammatory myopathiesArun S Varadhachary, Conrad C Weihl, Alan PestronkMuscle & Nerve|June 18, 2015
Myelinated and unmyelinated endoneurial axon quantitation and clinical correlationAmir Dori, Glenn Lopate, Rati Choksi, et al.Neurology|June 16, 2006
Valproate may improve strength and function in patients with type III/IV spinal muscle atrophyConrad C Weihl, Anne M Connolly, Alan PestronkPageof 14